Venture Capital Archives - Page 31 of 111 - Boston Life Sciences Times

eClinical Solutions Appoints Lauren Whitsell as Chief Operating Officer and Venu Mallarapu as Chief Transformation and AI Officer

March 13, 2026

Casma Therapeutics Secures $7.6 Million in MJFF Funding to Advance Parkinson’s Disease Program

March 10, 2026

NEJM Publishes Data Suggesting Zorevunersen May Modify Disease Course in Dravet Syndrome

March 5, 2026

THIS WEEK'S STORIES

Odyssey Therapeutics Appoints H. Martin Seidel, Ph.D., to Scientific Advisory Board

March 10, 2026

Allurion Appeals NYSE Delisting Decision as It Pursues Plan to Regain Listing Compliance

March 13, 2026

MindImmune Secures $5 Million Investment from Alzheimer’s Drug Discovery Foundation to Advance Alzheimer’s Therapy

March 10, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Venture Capital

Vicarious Surgical Unveils Strategy to Seek Nasdaq Listing While Cutting Cash Burn

Cambridge Startup Axiomatic AI Raises $18M to Build Verified AI Platform for Engineering

Cognito Therapeutics Raises $105 Million Series C to Advance Alzheimer’s Therapy Platform

Poplar Therapeutics Raises $45 Million to Advance Anti-IgE Therapy for Food Allergy and Atopic Diseases

BreezeBio Raises $60 Million in Series B to Advance Precision Genetic Medicines Pipeline

Most Read

Boston Maintains Global Life Sciences Leadership Despite Rising Lab Vacancies

Eccogene Enrolls First Patient in Phase 2a Trial Testing ECC4703 With Semaglutide for Obesity

The Hartford Expands Support for Active Minds’ Send Silence Packing Tour to Promote Student Mental Health

Form Health Launches Diabetes Program, Expanding Integrated Cardiometabolic Care for Employers

EDITOR PICKS

eClinical Solutions Appoints Lauren Whitsell as Chief Operating Officer and Venu Mallarapu as Chief Transformation and AI Officer

Casma Therapeutics Secures $7.6 Million in MJFF Funding to Advance Parkinson’s Disease Program

NEJM Publishes Data Suggesting Zorevunersen May Modify Disease Course in Dravet Syndrome

THIS WEEK'S STORIES

Odyssey Therapeutics Appoints H. Martin Seidel, Ph.D., to Scientific Advisory Board

Allurion Appeals NYSE Delisting Decision as It Pursues Plan to Regain Listing Compliance

MindImmune Secures $5 Million Investment from Alzheimer’s Drug Discovery Foundation to Advance Alzheimer’s Therapy

POPULAR CATEGORY

ABOUT US

FOLLOW US